Literature DB >> 22484399

Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis.

Jason E Dodge1, Allan L Covens, Christina Lacchetti, Laurie M Elit, Tien Le, Michaela Devries-Aboud, Michael Fung-Kee-Fung.   

Abstract

OBJECTIVE: To systematically review the existing literature in order to determine the optimal strategy for preoperative identification of the adnexal mass suspicious for ovarian cancer.
METHODS: A review of all systematic reviews and guidelines published between 1999 and 2009 was conducted as a first step. After the identification of a 2004 AHRQ systematic review on the topic, searches of MEDLINE for studies published since 2004 was also conducted to update and supplement the evidentiary base. A bivariate, random-effects meta-regression model was used to produce summary estimates of sensitivity and specificity and to plot summary ROC curves with 95% confidence regions.
RESULTS: Four meta-analyses and 53 primary studies were included in this review. The diagnostic performance of each technology was compared and contrasted based on the summary data on sensitivity and specificity obtained from the meta-analysis. Results suggest that 3D ultrasonography has both a higher sensitivity and specificity when compared to 2D ultrasound. Established morphological scoring systems also performed with respectable sensitivity and specificity, each with equivalent diagnostic competence. Explicit scoring systems did not perform as well as other diagnostic testing methods. Assessment of an adnexal mass by colour Doppler technology was neither as sensitive nor as specific as simple ultrasonography. Of the three imaging modalities considered, MRI appeared to perform the best, although results were not statistically different from CT. PET did not perform as well as either MRI or CT. The measurement of the CA-125 tumour marker appears to be less reliable than do other available assessment methods.
CONCLUSION: The best available evidence was collected and included in this rigorous systematic review and meta-analysis. The abundant evidentiary base provided the context and direction for the diagnosis of early-staged ovarian cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22484399     DOI: 10.1016/j.ygyno.2012.03.048

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  20 in total

1.  Serum microRNA-145 as a novel biomarker in human ovarian cancer.

Authors:  Huichao Liang; Zhipeng Jiang; Guie Xie; Yan Lu
Journal:  Tumour Biol       Date:  2015-02-27

Review 2.  Role of Three-Dimensional Ultrasound in Gynecology.

Authors:  Engin Turkgeldi; Bulent Urman; Baris Ata
Journal:  J Obstet Gynaecol India       Date:  2014-11-08

3.  Hysteroscopy is Superior to 3D Ultrasound in Gynecological Diagnosis.

Authors:  Fessy Louis; Chander P Lulla
Journal:  J Obstet Gynaecol India       Date:  2020-12-04

4.  MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.

Authors:  Ying-Chun Gao; Jie Wu
Journal:  Tumour Biol       Date:  2015-02-01

5.  Plasma immune analytes in patients with epithelial ovarian cancer.

Authors:  Matthew S Block; Matthew J Maurer; Krista Goergen; Kimberly R Kalli; Courtney L Erskine; Marshall D Behrens; Ann L Oberg; Keith L Knutson
Journal:  Cytokine       Date:  2015-03-03       Impact factor: 3.861

6.  Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses.

Authors:  Patrick N Pereira; Luis O Sarian; Adriana Yoshida; Karla G Araújo; Ricardo H O Barros; Ana C Baião; Daniella B Parente; Sophie Derchain
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

7.  Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian Cancer.

Authors:  Khawla Al-Musalhi; Manal Al-Kindi; Fatma Ramadhan; Thuraya Al-Rawahi; Khalsa Al-Hatali; Waad-Allah Mula-Abed
Journal:  Oman Med J       Date:  2015-11

8.  Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.

Authors:  Casina W S Kan; Michael A Hahn; Gregory B Gard; Jayne Maidens; Jung Yoon Huh; Deborah J Marsh; Viive M Howell
Journal:  BMC Cancer       Date:  2012-12-28       Impact factor: 4.430

9.  Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies.

Authors:  J Kaijser
Journal:  Facts Views Vis Obgyn       Date:  2015

10.  Paraneoplastic neurological syndromes: severe neurological symptoms resulting from relatively benign or occult tumours-two case reports.

Authors:  M Ghadiri-Sani; Mueez Waqar; Dave Smith; Mark Doran
Journal:  Case Rep Oncol Med       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.